Softabs-designing sugar-free viscoelastic drug delivery capsules for hydrophobic cannabinoid, nutraceutical, and pharmacological delivery across mucosal membranes

Cannabinoids, especially cannabidiol show promise as medicinal agents and are often now proscribed for a variety of indications. One of the major challenges is the lack of a standard dose, and safe ways to ingest. Smoking dried plant material causes harmful particles to enter the lungs, while homemade “edibles” can both vary in their potency and as they must pass through the liver due to digestion, can lead to different levels of cannabidiol entering the blood of different people. Oil tinctures are adsorbed across the mucosal membranes in the mouth, but are foul. The proposed SofTabs are also transmucosal, but are far more palatable, and provide a defined dose in a simple form. In this partnership, SofTab Technologies and the University of Windsor Team are designing and evaluating new and improved formulations of these SofTabs to provide certainty in dose, and a convenient chewable formulation.

Faculty Supervisor:

John Trant;Simon Rondeau-Gagné

Student:

Partner:

Softab Technologies

Discipline:

Physics

Sector:

Manufacturing

University:

University of Windsor

Program: